Terms ending in 2028
Yeda Research and Development Co. Ltd.
Every in-force patent on Yeda Research and Development Co. Ltd.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,326,147 | Redirected, Genetically-Engineered T Regulatory Cells and Their Use in Suppression of Autoimmune and Inflammatory Disease In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | |
| US 8,486,653 | Antibodies and Pharmaceutical Compositions Containing Same Useful for Inhibiting Activity of Metalloproteins In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 9,902,783 | Antibodies and Pharmaceutical Compositions Containing Same Useful for Inhibiting Activity of Metalloproteins In force · Medium confidence | Yeda Research and Development Co. Ltd. | In force | Medium confidence | |
| US 8,172,763 | Imaging and Analysis of Movement of Erythrocytes in Blood Vessels in Relation to the Cardiac Cycle In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | |
| US 7,976,451 | Transcranial Magnetic Stimulation System and Methods In force · High confidence | Brainsway, Ltd. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Yeda Research and Development Co. Ltd..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.